Legislative Session Starts; MMA to Focus on 5 Major Issues
February 19, 2026
State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium.
January 8, 2026
The Minnesota Department of Human Services (DHS) has two open physician seats on its Minnesota Health Care Program’s Drug Utilization Review (DUR) Board.
The board was formed to:
monitor the prescription of covered outpatient drugs for recipients of Medicaid,
oversee prospective and retrospective interventions to target common drug therapy problems,
monitor the landscape of opioid and psychotropic medication prescribing, and
assess financial impact of interventions in the fee-for-service (FFS) Minnesota Medicaid population.
Qualified applicants must be actively practicing MDs or DOs in Minnesota with knowledge of appropriate prescribing, dispensing, and monitoring of covered outpatient drugs.
The DUR Board meets four times annually for up to two hours. There are options for in-person or virtual attendance, and Board members receive a $100 stipend per meeting attended. Term length is three years.
Applications are accepted through the Office of the Minnesota Secretary of State Boards and Commissions website, or via e-mail request to Erin Neumann, DUR coordinator. Applications received before February 6 will be considered for appointment at the March 2026 DUR Board meeting.
For more information, reach out to Erin Neumann.
February 19, 2026
State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium.
February 19, 2026
On the second day of the legislative session, MMA leadership was already advocating for one of its top priorities - minimizing the harm of federal changes to Medical Assistance (MA).
February 19, 2026
Legislation to prohibit the use of artificial intelligence (AI) in prior authorization requirements was heard in the House Commerce Finance and Policy Committee on February 19.